TrialJournal of medical virology2026

Tenofovir Alafenamide in the Treatment of Chronic Hepatitis B Virus Infection in the High-Replicative Low-Inflammatory Phase: A 48-Week Randomized Controlled Trial.

Qiumin Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.